- Home
- OCGN vs DOMO Comparison
OCGN vs DOMO Comparison
Compare OCGN & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- DOMO
- Stock Information
- Founded
- OCGN 2013
- DOMO 2010
- Country
- OCGN United States
- DOMO United States
- Employees
- OCGN N/A
- DOMO N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- DOMO Computer Software: Prepackaged Software
- Sector
- OCGN Health Care
- DOMO Technology
- Exchange
- OCGN Nasdaq
- DOMO Nasdaq
- Market Cap
- OCGN 338.2M
- DOMO 286.1M
- IPO Year
- OCGN N/A
- DOMO 2018
- Fundamental
- Price
- OCGN $0.99
- DOMO $9.01
- Analyst Decision
- OCGN Strong Buy
- DOMO Hold
- Analyst Count
- OCGN 3
- DOMO 5
- Target Price
- OCGN $5.33
- DOMO $9.60
- AVG Volume (30 Days)
- OCGN 3.5M
- DOMO 287.7K
- Earning Date
- OCGN 11-08-2024
- DOMO 11-29-2024
- Dividend Yield
- OCGN N/A
- DOMO N/A
- EPS Growth
- OCGN N/A
- DOMO N/A
- EPS
- OCGN N/A
- DOMO N/A
- Revenue
- OCGN $7,263,000.00
- DOMO $318,369,000.00
- Revenue This Year
- OCGN N/A
- DOMO $0.39
- Revenue Next Year
- OCGN N/A
- DOMO N/A
- P/E Ratio
- OCGN N/A
- DOMO N/A
- Revenue Growth
- OCGN 112.62
- DOMO 0.19
- 52 Week Low
- OCGN $0.35
- DOMO $6.11
- 52 Week High
- OCGN $2.11
- DOMO $12.23
- Technical
- Relative Strength Index (RSI)
- OCGN 50.03
- DOMO 69.41
- Support Level
- OCGN $0.91
- DOMO $7.76
- Resistance Level
- OCGN $0.98
- DOMO $8.53
- Average True Range (ATR)
- OCGN 0.07
- DOMO 0.33
- MACD
- OCGN 0.02
- DOMO 0.11
- Stochastic Oscillator
- OCGN 40.08
- DOMO 90.50
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About DOMO Domo Inc. Class B
Domo Inc provides a cloud-based platform that digitally connects all the data, systems and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.